What is Organon's remainder of 2026?

Organon (OGN) reported remainder of 2026 of $1M in Q1 2026.

How has Organon's remainder of 2026 changed year-over-year?

Organon's remainder of 2026 decreased by 83.3% year-over-year, from $6M to $1M.

Organon OGN Remainder of 2026

Remainder of 2026 at other companies

PBH

Prestige Consumer HealthcarePBH

——

Bausch + LombBLCO

——

Other financials

Income statement

See full

Revenue$1.5B-3.5%

Gross profit$783.0M-6.9%

Net income$146.0M+67.8%

EPS (diluted)$0.55+66.7%

Balance sheet

See full

Cash & equivalents$1.1B+104%

Total debt$8.6B-4.3%

Total equity$903.0M+66.6%

Total assets$13.0B-1.2%

Cash flow

See full

Operating cash flow$225.0M+200%

CapEx$37.0M+15.6%

Free cash flow$188.0M+337%

Valuation

See full

Market cap$3.53B-59.4%

Profitability

See full

Gross margin52.8%-4.4pp

Net margin8%-12.3pp

FCF margin11.1%-1.3pp

Returns & leverage

See full

Return on equity71.6%—

Debt / equity9.5×-7.0×

Current ratio2×+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's remainder of 2026.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Organon's remainder of 2026?: Organon (OGN) reported remainder of 2026 of $1M in Q1 2026.
How has Organon's remainder of 2026 changed year-over-year?: Organon's remainder of 2026 decreased by 83.3% year-over-year, from $6M to $1M.